Gene Query: SERPINB1

Dataset Description Geneva Score
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 89.54
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II) 85.1
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 80.64
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 78.21
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 78.21
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 70.67
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 66.88
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 64.17
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 64.17
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 62.39
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 62.39
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 60.46
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 57.18
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 56.82
Gene expression changes associated with resistance to tagraxofusp (SL-401) 54.16
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 53.57
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 52.54
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 50.05
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 47.9
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 46.21
Identifying the molecular mode of action of itraconazole in colorectal cancer 44.06
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 42.43
Effect of BMP inhibition or stimulation of primary human keratinocytes 42.43
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 42.12
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 40.83
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 40.83
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 38.79
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 38.78
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 38.78
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 38.55
JunB control of keratinocyte-mediated inflammation [RNA-seq] 38.55
WRN knockout effects upon gene expression in SW48 and OVK18 38.33
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 38.14
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 37.33
FOXD3 is a novel tumor suppressor in lung cancer 36.76
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 35.22
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 33.86
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 33.02
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 32.51
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 30.68
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 30.44
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 30.37
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 29.57
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 29.13
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 28.27
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 28.19
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 28.12
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 27.99
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 27.99
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 27.89
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 27.36
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 27.34
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 27.26
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 26.88
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 26.22
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 25.41
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 25.26
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 25.15
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 24.79
Human cells contain natural double-stranded RNAs with potential regulatory capacity 24.68
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 24.46
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 23.96
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 23.87
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 22.95
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 22.95
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 22.87
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 22.78
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 22.78
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 22.78
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 22.78
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 22.72
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 22.56
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 22.45
Transcriptome analysis of SKI knock-out in HL60 cells 22.36
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 22.36
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 22.27
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 21.97
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 21.96
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 21.7
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 21.57
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 21.54
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 21.24
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 21.05
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 20.86
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 20.41
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 20.29
HNF1 regulates critical functions of the human epididymis epithelium. 20.24
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 20.24
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 20.23
G-quadruplex structures mark human regulatory chromatin 20.1
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 20.07
TGF-β promotes genomic instability after loss of RUNX3 20.06
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 19.92
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 19.72
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 19.68
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 19.68
RNAseq of IL-36 stimulated primary human keratinocytes 19.65
MEIS1 regulates hematopoiesis in hPSCs 19.37
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 19.29
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 19.21
Peptidomimetic blockade of MYB in acute myeloid leukemia 19.21
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 19.07
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 18.99
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 18.97
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 18.82
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 18.78
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 18.78
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 18.74
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 18.59
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 18.55
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 18.48
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 18.3
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 18.29
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 18.04
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 18.04
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 17.95
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 17.91
Gene expression changes caused by KRAS in MCF-10A 17.57
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 17.5
Targeting MTHFD2 in Acute Myeloid Leukemia 17.46
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 17.46
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 17.3
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 17.25
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 17.21
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 17.17
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 17.17
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 17.11
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 17.11
Endothelial gene expression analysis 17.1
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 17.1
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 17.1
Morphological and molecular characterization of human dermal lymphatic collectors 17.04
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 17.03
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 16.93
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 16.93
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 16.86
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 16.78
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 16.74
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 16.66
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 16.66
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 16.56
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 16.34
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 16.29
RNA-seq analysis of AML cells in response to ASLAN003 16.15
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 16.11
EWSR1 influences alternative splicing through direct and indirect mechanisms 15.9
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 15.81
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 15.69
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 15.64
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 15.61
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 15.44
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 15.37
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 15.37
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 15.37
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 15.26
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 15.15
RNA-seq analysis of breast cancer 15.14
RNA-seq analysis and shRNA screen of breast cancer 15.14
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 14.92
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 14.77
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 14.74
Effect of BB608 on Gene Expression in HNSCC Cell Line 14.65
Genome wide expression change by RNF168 knocking down in NEC cells 14.48
oxLDL exposed trained monocytes 14.38
Transcriptomes of oxLDL exposed trained monocytes 14.38
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 14.35
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 14.35
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 14.33
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 14.32
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 14.28
RNA-seq of YB5 cells treated with Proscillaridin A 14.21
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 14.04
IL-33 activates tumor stroma to promote intestinal polyposis 13.98
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 13.97
RNA-seq of IL-4 stimulated human keratinocytes 13.95
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 13.88
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 13.88
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 13.83
Accurate annotation of human protein-coding small open reading frames 13.82
Trans-differentiation of human adult peripheral blood T cells into neurons 13.73
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 13.73
Characterization of the Merkel cell carcinoma miRNome 13.69
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 13.58
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 13.58
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 13.42
Role of cervicovaginal microbiota in genital inflammation 13.4
Total RNA sequencing of APC mutant and wt colonic organoids 13.38
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 13.38
Control of prostate tumour growth by the long non-coding RNA GHSROS 13.32
Dynamic 3D chromosomal landscapes in acute leukemia 13.29
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 13.29
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 13.24
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 13.22
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 13.19
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 13.17
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 13.17
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 13.14
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 13.06
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 13.06
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 13.05
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 13.0
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 12.95
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 12.91
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 12.78
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 12.66
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 12.66
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 12.65
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 12.62
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 12.31
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 12.28
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 12.18
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 12.13
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 12.06
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 12.01
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 12.0
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 11.97
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 11.96
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 11.95
Regulation of Lipids is Central to Replicative Senescence 11.88
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 11.86
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 11.8
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 11.78
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 11.74
Regulatory network controlling tumor-promoting inflammation in human cancers 11.72
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 11.72
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 11.64
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 11.55
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 11.52
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 11.52
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 11.49
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 11.48
Transcriptome of activated human and mouse MAIT cells 11.45
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 11.43
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 11.41
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 11.35
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 11.34
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 11.34
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 11.27
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 11.26
RNA-sequencing of human tendon after injury 11.23
MARCKS and lnc-MARCKS act as inflammation regulators 11.22
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 11.2
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 11.17
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 11.13
Hypoxic transcriptome of SQ20B human head and neck cancer cells 11.12
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 11.1
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 11.04
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 11.0
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 10.9
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 10.85
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 10.83
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 10.82
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 10.82
ARID1A regulates condensin II distribution and chromosomal partition 10.82
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 10.82
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 10.81
Transcriptome of EBV-infected gastric cancer cell lines 10.81
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 10.77
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 10.76
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 10.73
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 10.69
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 10.67
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 10.67
Short and Long RNA sequencing of human mature erythrocytes 10.64
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 10.63
circRNA profile in hypopharyngeal cancer 10.62
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 10.6
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 10.53
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 10.48
LncRNA-GAS5 negative regulation of YAP-target genes expression 10.47
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 10.45
Gene expression analysis of human liver progenitor-like cells in culture 10.42
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 10.39
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 10.34
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 10.34
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 10.33
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 10.33
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 10.31
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.19
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 10.1
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 10.0
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 9.97
IRF2 is a master regulator of human keratinocyte stem cell fate 9.89
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 9.89
Widespread regulated alternative splicing of single codons accelerates proteome evolution 9.86
RNA-seq of cells with TET1 knockout 9.81
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 9.76
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 9.76
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 9.74
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 9.74
Transcriptomic analysis of human tonsillar TFH subsets 9.71
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 9.67
Loss of CREBBP results in gene expression repression in lymphoma cells 9.67
Gene expression profile of multiple myeloma cell lines treated with CB-5083 9.62
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 9.59
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 9.59
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 9.55
Zone dependent distinctive gene expression profile of the normal human liver tissue 9.55
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 9.53
Primate transcript and protein expression levels evolve under compensatory selection pressures 9.48
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 9.45
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 9.41
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 9.41
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 9.26
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 9.23
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 9.18
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 9.06
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 9.02
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 8.89
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 8.89
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 8.84
Trascriptome of thyroid cancer-induced macrophages 8.78
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 8.75
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  8.7
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 8.48
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 8.44
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 8.43
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 8.43
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 8.42
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 8.4
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 8.39
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 8.36
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 8.34
Hepatitis C virus functionally sequesters miR-122 8.32
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 8.32
RNA-seq of cancer cell lines treated with T-025 8.31
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 8.29
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 8.24
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 8.21
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 8.21
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 8.2
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 8.18
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 8.15
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 8.12
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 8.0
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 8.0
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 7.99
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 7.91
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 7.9
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 7.83
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 7.83
Characterization of parental and rociletinib-resistant derived H1975 cell lines 7.81
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 7.8
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 7.73
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 7.7
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 7.7
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 7.68
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 7.52
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 7.51
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.49
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 7.47
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 7.47
Transcriptome profiling of Normal and Cancerous Prostate Cells 7.43
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 7.3
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 7.3
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 7.26
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 7.18
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 7.14
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 6.96
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 6.85
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 6.78
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 6.67
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 6.67
Statins modulate endothelial transcriptional profile by inhibiting EZH2 6.52
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 6.5
RNA-sequencing in immortalized human mammary epithelial cells 6.37
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 6.37
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 6.28
Fusion discovery in breast cancer cell line 6.23
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 6.2
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 6.18
Efficient derivation of microglia-like cells from human pluripotent stem cells 6.17
Identification of long noncoding RNAs in T-ALL cell lines 6.1
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 6.09
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 6.03
Direct Isolation and Characterization of Human Nephron Progenitors. 5.96
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 5.96
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 5.86
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 5.85
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 5.78
Gene Expression Profiling of WT and KDM3A Knocked out Cell 5.76
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 5.76
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 5.75
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 5.73
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 5.73
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 5.68
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 5.57
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 5.56
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 5.54
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 5.54
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 5.49
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 5.48
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.32
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.28
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 5.2
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 5.2
Human T-cell lymphoblastic lymphoma samples and control thymuses 5.2
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 5.2
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 5.1
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  5.09
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 5.05
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 5.03
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 4.86
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.86
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 4.85
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 4.83
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 4.73
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 4.62
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 4.46
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 4.41
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 4.39
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 4.26
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 4.23
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 4.22
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 4.0
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 3.95
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 3.91
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.9
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.85
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.8
Transcriptome analysis of peripheral blood monocytes 3.75
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 3.6
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 3.6
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.52
The cytokine environment influence on human skin-derived T cells 3.38
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 3.34
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.24
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.24
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 3.12
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 3.12
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.11
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.81
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.75
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.62
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 2.55
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 2.43
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.36
RNA splicing alteration on glioblastoma and normal neural stem cells 2.23
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 2.07
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.06
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 2.02
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.94
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.87
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 1.87
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.83
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.77
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.74
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.65
Transcriptome wide analysis of classically and alternatively activated macrophages 1.65
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 1.63
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.58
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.58
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 1.55
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.45
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.45
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.43
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.36
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.35
MRTF activates TEAD-YAP target gene expression 1.24
MHC Transcriptomic landscape at haplotype-specific resolution 1.23
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.06
Energy Metabolism during Anchorage-Independence 1.01
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.89
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.89
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.88
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.85
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.85
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.82
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.82
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.8
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.77
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.74
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.74
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.72
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.72
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.7
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.64
Identification of long noncoding RNAs regulated by p53 0.63
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 0.62
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.59
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.54
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.51
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.47
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 0.45
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.38
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.37
Selective expression of long non-coding RNAs in a breast cancer cell progression model 0.35
ML29755 RNA-seq data 0.3
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 0.3
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.28
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.26
The Genetic Landscape of Diamond-Blackfan Anemia 0.18
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.15
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.1
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.09
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.02
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.02
Metastasis in triple-negative breast cancer 0.02
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.0
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation